Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Safety and Primary Patency Between FUSION Vascular Graft With Bioline and EXXCEL Soft ePTFE (FINEST)

NCT01113892 is registered in ClinicalTrials.gov with Maquet Cardiovascular as lead sponsor.

NCT NCT01113892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01113892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Safety and Primary Patency Between FUSION Vascular Graft With Bioline and EXXCEL Soft ePTFE (FINEST)
Lead sponsor
Maquet Cardiovascular
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2010
Completion date
June 4, 2013
Enrollment
207 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial occlusive disease